HEADER CYTOSOLIC PROTEIN 30-SEP-19 6SYN TITLE CRYSTAL STRUCTURE OF Y. PESTIS PENICILLIN-BINDING PROTEIN 3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDOGLYCAN D,D-TRANSPEPTIDASE FTSI; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PENICILLIN-BINDING PROTEIN 3,PBP-3; COMPND 5 EC: 3.4.16.4; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: YERSINIA PESTIS; SOURCE 3 ORGANISM_TAXID: 632; SOURCE 4 GENE: FTSI, YPO0549; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CLASS B PBP, YERSINIA PESTIS, HMM TRANSPEPTIDASE, PERIPLASMIC KEYWDS 2 PROTEIN, CYTOSOLIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.PANKOV,W.N.HUNTER,A.DAWSON REVDAT 3 23-OCT-24 6SYN 1 REMARK REVDAT 2 24-JAN-24 6SYN 1 REMARK REVDAT 1 14-OCT-20 6SYN 0 JRNL AUTH G.PANKOV JRNL TITL THE STRUCTURE OF PENICILLIN-BINDING PROTEIN 3 FROM YERSINIA JRNL TITL 2 PESTIS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.63 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.63 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 13830 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 752 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.63 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.70 REMARK 3 REFLECTION IN BIN (WORKING SET) : 924 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.82 REMARK 3 BIN R VALUE (WORKING SET) : 0.2460 REMARK 3 BIN FREE R VALUE SET COUNT : 55 REMARK 3 BIN FREE R VALUE : 0.4570 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3570 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 144 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 8.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.37000 REMARK 3 B22 (A**2) : -0.46000 REMARK 3 B33 (A**2) : 0.83000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.382 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.288 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.841 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.895 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.819 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3679 ; 0.003 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 3529 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4997 ; 1.388 ; 1.645 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8144 ; 1.113 ; 1.572 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 468 ; 6.951 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 174 ;32.183 ;20.862 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 599 ;17.665 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 29 ;19.034 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 483 ; 0.060 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4118 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 761 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6SYN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-SEP-19. REMARK 100 THE DEPOSITION ID IS D_1292104556. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JAN-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14613 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.630 REMARK 200 RESOLUTION RANGE LOW (A) : 36.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.12200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.63 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.23400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4BJP REMARK 200 REMARK 200 REMARK: RECTANGULAR PRISMS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 UL OF PROTEIN (IN 20 MM TRIS-HCL REMARK 280 PH 7.5 150 MM NACL AND 2 MM CARBENICILLIN) AT 6.7 MG/ML AND 0.2 REMARK 280 UL OF PRECIPITANT (0.2 M MAGNESIUM ACETATE, 0.1 M SODIUM REMARK 280 CACODYLATE PH 6.5 AND 20% PEG 8000), VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.47500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.21000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.47500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 55.21000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 55 REMARK 465 MET A 56 REMARK 465 ASP A 57 REMARK 465 MET A 58 REMARK 465 ARG A 59 REMARK 465 SER A 60 REMARK 465 LEU A 61 REMARK 465 ARG A 62 REMARK 465 VAL A 63 REMARK 465 GLN A 64 REMARK 465 GLU A 65 REMARK 465 GLN A 202 REMARK 465 PRO A 203 REMARK 465 GLY A 204 REMARK 465 GLU A 205 REMARK 465 ARG A 206 REMARK 465 THR A 207 REMARK 465 VAL A 208 REMARK 465 ARG A 209 REMARK 465 LYS A 210 REMARK 465 ASP A 211 REMARK 465 HIS A 212 REMARK 465 TYR A 213 REMARK 465 GLY A 214 REMARK 465 ARG A 215 REMARK 465 VAL A 216 REMARK 465 ILE A 217 REMARK 465 GLU A 218 REMARK 465 ASP A 219 REMARK 465 ILE A 220 REMARK 465 SER A 221 REMARK 465 SER A 222 REMARK 465 VAL A 223 REMARK 465 ASP A 224 REMARK 465 SER A 225 REMARK 465 GLN A 226 REMARK 465 GLY A 287 REMARK 465 THR A 288 REMARK 465 PRO A 289 REMARK 465 LYS A 290 REMARK 465 ASP A 291 REMARK 465 LEU A 567 REMARK 465 PRO A 568 REMARK 465 THR A 569 REMARK 465 GLY A 570 REMARK 465 ASP A 571 REMARK 465 LYS A 572 REMARK 465 SER A 573 REMARK 465 GLU A 574 REMARK 465 LEU A 575 REMARK 465 VAL A 576 REMARK 465 ILE A 577 REMARK 465 ASN A 578 REMARK 465 THR A 579 REMARK 465 LYS A 580 REMARK 465 GLU A 581 REMARK 465 GLY A 582 REMARK 465 SER A 583 REMARK 465 GLY A 584 REMARK 465 GLY A 585 REMARK 465 ARG A 586 REMARK 465 SER A 587 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 130 70.36 -116.91 REMARK 500 SER A 279 -158.46 -110.65 REMARK 500 ASP A 508 54.07 -95.16 REMARK 500 ASN A 522 73.71 -163.90 REMARK 500 PRO A 564 166.47 -49.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CB9 A 603 DBREF 6SYN A 57 587 UNP Q0WJB8 Q0WJB8_YERPE 57 587 SEQADV 6SYN HIS A 55 UNP Q0WJB8 EXPRESSION TAG SEQADV 6SYN MET A 56 UNP Q0WJB8 EXPRESSION TAG SEQRES 1 A 533 HIS MET ASP MET ARG SER LEU ARG VAL GLN GLU VAL PRO SEQRES 2 A 533 THR ALA ARG GLY MET ILE SER ASP ARG SER GLY ARG PRO SEQRES 3 A 533 LEU ALA VAL SER VAL PRO VAL ASN ALA VAL TRP ALA ASP SEQRES 4 A 533 PRO LYS GLU LEU ILE GLU GLN GLY GLY ILE SER LEU ASP SEQRES 5 A 533 THR ARG TRP LYS ALA LEU SER ASP ALA LEU GLU ILE PRO SEQRES 6 A 533 LEU ASP GLN LEU ALA THR ARG ILE ASN ALA ASN PRO LYS SEQRES 7 A 533 GLY ARG PHE VAL TYR LEU ALA ARG GLN VAL ASN PRO ALA SEQRES 8 A 533 ILE GLY ASP TYR ILE ARG LYS LEU LYS LEU PRO GLY ILE SEQRES 9 A 533 HIS LEU ARG GLN GLU SER ARG ARG TYR TYR PRO ALA GLY SEQRES 10 A 533 GLN VAL MET ALA HIS ILE ILE GLY VAL THR ASN ILE ASP SEQRES 11 A 533 GLY GLN GLY ILE GLU GLY VAL GLU LYS SER PHE ASP ARG SEQRES 12 A 533 TRP LEU THR GLY GLN PRO GLY GLU ARG THR VAL ARG LYS SEQRES 13 A 533 ASP HIS TYR GLY ARG VAL ILE GLU ASP ILE SER SER VAL SEQRES 14 A 533 ASP SER GLN ALA ALA HIS ASN LEU VAL LEU SER VAL ASP SEQRES 15 A 533 GLU ARG LEU GLN ALA LEU VAL TYR ARG GLU LEU ASN ASN SEQRES 16 A 533 ALA VAL ALA PHE ASN LYS ALA GLU SER GLY THR ALA VAL SEQRES 17 A 533 LEU VAL ASP VAL ASN THR GLY GLU VAL LEU ALA MET ALA SEQRES 18 A 533 ASN SER PRO SER TYR ASN PRO ASN ASN LEU THR GLY THR SEQRES 19 A 533 PRO LYS ASP ALA MET ARG ASN ARG ALA ILE THR ASP ILE SEQRES 20 A 533 PHE GLU PRO GLY SER THR VAL LYS PRO MET VAL VAL MET SEQRES 21 A 533 THR ALA LEU GLN HIS GLY VAL VAL LYS GLU ASN SER VAL SEQRES 22 A 533 LEU ASN THR LEU PRO TYR PHE VAL ASN GLY HIS GLN ILE SEQRES 23 A 533 LYS ASP VAL ALA ARG TYR ALA GLU LEU SER VAL THR GLY SEQRES 24 A 533 ILE LEU GLN LYS SER SER ASN VAL GLY VAL SER LYS LEU SEQRES 25 A 533 ALA LEU ALA MET PRO SER SER ALA LEU VAL ASP THR TYR SEQRES 26 A 533 SER ARG PHE GLY PHE GLY LYS ALA THR ASN LEU GLY LEU SEQRES 27 A 533 VAL GLY GLU SER SER GLY LEU TYR PRO LYS LYS GLN ARG SEQRES 28 A 533 TRP SER ASP ILE GLU ARG ALA THR PHE SER PHE GLY TYR SEQRES 29 A 533 GLY LEU MET VAL THR PRO LEU GLN LEU ALA ARG VAL TYR SEQRES 30 A 533 ALA THR ILE GLY SER MET GLY VAL TYR ARG PRO LEU SER SEQRES 31 A 533 ILE THR ARG VAL ASP PRO PRO VAL ALA GLY GLU ARG ILE SEQRES 32 A 533 PHE PRO GLU PRO LEU VAL ARG THR VAL VAL HIS MET MET SEQRES 33 A 533 GLU SER VAL ALA LEU PRO GLY GLY GLY GLY THR LYS ALA SEQRES 34 A 533 ALA ILE LYS GLY TYR ARG ILE ALA ILE LYS THR GLY THR SEQRES 35 A 533 ALA LYS LYS VAL GLY PRO ASP GLY LYS TYR MET ASP ARG SEQRES 36 A 533 TYR LEU ALA TYR THR ALA GLY VAL ALA PRO ALA SER ASN SEQRES 37 A 533 PRO ARG PHE ALA LEU VAL VAL VAL ILE ASN ASP PRO GLN SEQRES 38 A 533 ALA GLY LYS TYR TYR GLY GLY ALA VAL SER ALA PRO VAL SEQRES 39 A 533 PHE GLY ALA ILE MET GLY GLY VAL LEU ARG THR MET ASN SEQRES 40 A 533 ILE GLU PRO ASP ALA LEU PRO THR GLY ASP LYS SER GLU SEQRES 41 A 533 LEU VAL ILE ASN THR LYS GLU GLY SER GLY GLY ARG SER HET ACT A 601 4 HET ACT A 602 4 HET CB9 A 603 26 HETNAM ACT ACETATE ION HETNAM CB9 (2R,4S)-2-[(1R)-1-{[(2S)-2-CARBOXY-2- HETNAM 2 CB9 PHENYLACETYL]AMINO}-2-OXOETHYL]-5,5-DIMETHYL-1,3- HETNAM 3 CB9 THIAZOLIDINE-4-CARBOXYLIC ACID HETSYN CB9 BOUND FORM OF CARBENICILLIN FORMUL 2 ACT 2(C2 H3 O2 1-) FORMUL 4 CB9 C17 H20 N2 O6 S FORMUL 5 HOH *144(H2 O) HELIX 1 AA1 ASP A 93 GLN A 100 1 8 HELIX 2 AA2 THR A 107 GLU A 117 1 11 HELIX 3 AA3 PRO A 119 ALA A 129 1 11 HELIX 4 AA4 ASN A 143 LYS A 152 1 10 HELIX 5 AA5 MET A 174 GLY A 179 1 6 HELIX 6 AA6 GLU A 189 PHE A 195 1 7 HELIX 7 AA7 PHE A 195 THR A 200 1 6 HELIX 8 AA8 ASP A 236 ASN A 254 1 19 HELIX 9 AA9 ASN A 295 ASP A 300 1 6 HELIX 10 AB1 PRO A 304 THR A 307 5 4 HELIX 11 AB2 VAL A 308 HIS A 319 1 12 HELIX 12 AB3 VAL A 351 SER A 358 1 8 HELIX 13 AB4 SER A 359 ALA A 369 1 11 HELIX 14 AB5 SER A 372 PHE A 382 1 11 HELIX 15 AB6 SER A 407 SER A 415 1 9 HELIX 16 AB7 THR A 423 SER A 436 1 14 HELIX 17 AB8 PRO A 459 GLU A 471 1 13 HELIX 18 AB9 SER A 472 ALA A 474 5 3 HELIX 19 AC1 GLY A 480 ALA A 484 5 5 HELIX 20 AC2 TYR A 540 SER A 545 1 6 HELIX 21 AC3 SER A 545 MET A 560 1 16 SHEET 1 AA1 3 VAL A 136 VAL A 142 0 SHEET 2 AA1 3 PRO A 80 ALA A 92 -1 N VAL A 90 O LEU A 138 SHEET 3 AA1 3 ILE A 158 TYR A 167 -1 O TYR A 167 N VAL A 83 SHEET 1 AA2 4 VAL A 136 VAL A 142 0 SHEET 2 AA2 4 PRO A 80 ALA A 92 -1 N VAL A 90 O LEU A 138 SHEET 3 AA2 4 ILE A 73 SER A 74 -1 N ILE A 73 O LEU A 81 SHEET 4 AA2 4 LEU A 231 VAL A 232 1 O LEU A 231 N SER A 74 SHEET 1 AA3 5 VAL A 271 SER A 277 0 SHEET 2 AA3 5 SER A 258 ASP A 265 -1 N LEU A 263 O ALA A 273 SHEET 3 AA3 5 PHE A 525 ASN A 532 -1 O ALA A 526 N VAL A 264 SHEET 4 AA3 5 TYR A 506 ALA A 518 -1 N ALA A 512 O ILE A 531 SHEET 5 AA3 5 ALA A 491 VAL A 500 -1 N GLY A 495 O TYR A 513 SHEET 1 AA4 2 VAL A 327 ASN A 329 0 SHEET 2 AA4 2 GLU A 348 SER A 350 -1 O LEU A 349 N LEU A 328 SHEET 1 AA5 2 TYR A 333 VAL A 335 0 SHEET 2 AA5 2 HIS A 338 ILE A 340 -1 O ILE A 340 N TYR A 333 SHEET 1 AA6 2 VAL A 439 TYR A 440 0 SHEET 2 AA6 2 GLU A 455 ARG A 456 -1 O GLU A 455 N TYR A 440 LINK OG SER A 306 C CB9 A 603 1555 1555 1.34 CISPEP 1 SER A 277 PRO A 278 0 4.47 CISPEP 2 PRO A 450 PRO A 451 0 -9.23 CISPEP 3 ALA A 518 PRO A 519 0 -13.53 SITE 1 AC1 2 HOH A 749 HOH A 796 SITE 1 AC2 2 ARG A 238 THR A 559 SITE 1 AC3 12 SER A 306 VAL A 343 SER A 358 ASN A 360 SITE 2 AC3 12 TYR A 418 THR A 494 GLY A 495 THR A 496 SITE 3 AC3 12 TYR A 540 HOH A 704 HOH A 749 HOH A 777 CRYST1 40.860 104.950 110.420 90.00 90.00 90.00 P 2 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024474 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009528 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009056 0.00000